Coronary CT Angiography as a 'One-Stop Shop' to Detect the High-Risk Plaque and the Vulnerable Patient

This is a short editorial, but it captures a genuine shift in how cardiologists think about coronary CT angiography. The traditional question a scan answers is anatomical: how narrowed is the artery? The authors argue the test can do much more.

Their “one-stop shop” framing is that a single CT scan can move beyond measuring stenosis to characterizing the plaque itself — its composition, its high-risk features, and even, through analysis of the fat surrounding the artery, the inflammation driving it. In this view, CT angiography becomes a tool not just for finding blockages but for identifying the vulnerable plaque, and the vulnerable patient, before a rupture happens.

Written as a commentary on the FORECAST trial, it is a perspective piece rather than primary evidence. It synthesizes a direction the field is moving rather than proving any single claim, and its enthusiasm runs ahead of the outcomes data.

We rate the evidence limited by design — it is expert opinion, not a study. But its clinical significance is more than its grade suggests, because it articulates clearly the ambition behind modern coronary imaging: to see disease early and act before the event, which is the whole point of looking inside the artery at all.